Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06056453 · ClinicalTrials.gov registry record · NA

Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT06056453: Completed NA study, sponsored by University of Colorado, Denver.

NCT06056453 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06056453, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The main purpose of this study is to find out whether taking part in a group-based interpersonal psychotherapy (IPT) program designed to improve mood and lessen stress in girls with PCOS will improve depression, unhealthy eating behaviors, weight, and insulin resistance.

Primary Outcome

Depression symptoms will be assessed by the Center for Epidemiologic Studies-Depression Scale. Scores range from 1 to 4. The scoring of positive items is reversed. Possible range of scores is zero to 60, with the higher scores indicating the presence of more symptomatology.

Interventions

  • BEHAVIORAL Interpersonal Psychotherapy

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-09-20
Est. Completion 2023-07-14
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT06056453 record still lists

NCT06056453 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Interpersonal Psychotherapy is the first listed.

NCT06056453 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06056453 about?

NCT06056453 is a clinical study titled "Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome". The main purpose of this study is to find out whether taking part in a group-based interpersonal psychotherapy (IPT) program designed to improve mood and lessen stress in girls with PCOS will improve depression, unhealthy eating behaviors, weight, and insulin resistance.

What is the current status of trial NCT06056453?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-09-20. Estimated completion is 2023-07-14.

What interventions are being tested in trial NCT06056453?

The interventions under investigation include: Interpersonal Psychotherapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06056453?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06056453's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06056453, the US trial registry maintained by the National Library of Medicine. NCT06056453 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.